ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational

Luca Moscetti1,2, Lucia Mentuccia3, Patrizia Vici4

  • 1Division of Medical Oncology, AUSL Viterbo, Belcolle Hospital, Viterbo, Italy.

Abstract